RVL Pharmaceuticals plc (RVLPQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -37.81 Million | -54.73 Million | 17.59 Million | 33.56 Million | 37.55 Million | 57.83 Million |
| Net Income | -51.69 Million | -64.92 Million | -79.58 Million | -270.9 Million | -109.68 Million | -41.14 Million |
| Depreciation & Amortization | 375 Thousand | 8.17 Million | 21.02 Million | 57.01 Million | 81.59 Million | 46.45 Million |
| Deferred income taxes | -90 Thousand | -194 Thousand | -1.15 Million | -26.79 Million | -15.51 Million | -48.5 Million |
| Stock-based compensation | 4.07 Million | 7.59 Million | 4.92 Million | 4.93 Million | - | - |
| Change in working capital | 4.38 Million | -7.46 Million | -1.85 Million | -15.77 Million | -25.85 Million | 9.48 Million |
| Other non-cash items | -6.02 Million | 1.99 Million | 1.76 Million | 1.33 Million | 306 Million | 175.69 Million |
| Investing Cash Flow | 126 Thousand | 116.45 Million | -3.08 Million | -4.02 Million | -4.13 Million | -19.39 Million |
| Investments in PPE | -752 Thousand | -1.78 Million | -3.13 Million | -4.03 Million | -4.14 Million | -6.89 Million |
| Acquisitions | 878 Thousand | 90 Thousand | 50 Thousand | 17 Thousand | 10 Thousand | -12.5 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 878 Thousand | 118.14 Million | - | - | - | - |
| Financing Cash Flow | 41.78 Million | -135.33 Million | 3.68 Million | -4.69 Million | 3.6 Million | -23.31 Million |
| Debt repayment | -18.1 Million | -167.19 Million | -50.12 Million | -1.9 Million | -54.47 Million | -14.93 Million |
| Dividends payments | - | - | - | - | -2000.00 | - |
| Common Stock Repurchased | - | - | -8.1 Million | -2.78 Million | - | - |
| Common Stock Issuance | 23.63 Million | 32.41 Million | 62.44 Million | - | 58.08 Million | - |
| Other Financing Activities | -143 Thousand | -783 Thousand | -749 Thousand | - | - | -8.38 Million |
| Accounts receivables | -898 Thousand | 7.1 Million | 17.49 Million | 12.67 Million | -17.04 Million | 5.26 Million |
| Accounts payables | -1.37 Million | -134 Thousand | -1.72 Million | -16.37 Million | -11.32 Million | 588.23 Thousand |
| Inventory | 54 Thousand | 2.59 Million | 3.37 Million | 3.07 Million | -7.43 Million | 2.89 Million |
| Other working capital | 6.6 Million | -17.03 Million | -21 Million | -15.15 Million | 9.94 Million | 737.37 Thousand |
| Cash at beginning of period | 40.44 Million | 114.05 Million | 95.86 Million | 70.83 Million | 34.74 Million | 19.55 Million |
| Cash at end of period | 44.54 Million | 40.44 Million | 114.05 Million | 95.86 Million | 70.83 Million | 34.74 Million |
| Capital Expenditure | -752 Thousand | -1.78 Million | -3.13 Million | -4.03 Million | -4.14 Million | -6.89 Million |
| Effect of forex changes on cash | - | - | - | 175 Thousand | - | - |
| Net cash flow / Change in cash | 4.09 Million | -73.6 Million | 18.18 Million | 25.03 Million | 36.09 Million | 15.18 Million |
| Free Cash Flow | -38.56 Million | -56.51 Million | 14.45 Million | 29.53 Million | 33.41 Million | 50.94 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -23.88 Million | -11.61 Million | -18.31 Million | -51.69 Million | -14.44 Million | -12.1 Million |
| Depreciation & Amortization | 94 Thousand | 93 Thousand | 100 Thousand | 375 Thousand | 95 Thousand | 91 Thousand |
| Deferred income taxes | -48 Thousand | 11 Thousand | -128 Thousand | -90 Thousand | 15 Thousand | 14 Thousand |
| Stock-based compensation | 232 Thousand | 499 Thousand | 894 Thousand | 4.07 Million | - | - |
| Change in working capital | -2.45 Million | 813 Thousand | -4.38 Million | 4.38 Million | 4.04 Million | 17.53 Million |
| Other non-cash items | 1 Million | 5.13 Million | -400 Thousand | -6.02 Million | 360 Thousand | -20.1 Million |
| Investing Cash Flow | -959 Thousand | -1.22 Million | -172 Thousand | 126 Thousand | 231 Thousand | 57 Thousand |
| Investments in PPE | -1.04 Million | -1.3 Million | -700 Thousand | -752 Thousand | -25 Thousand | - |
| Acquisitions | 87 Thousand | 79 Thousand | 528 Thousand | 878 Thousand | 256 Thousand | 57 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 87 Thousand | - | - | - | - | - |
| Financing Cash Flow | -460 Thousand | -4.86 Million | 1.39 Million | 41.78 Million | 42.2 Million | -981 Thousand |
| Debt repayment | -443 Thousand | -4.88 Million | -1.42 Million | -18.1 Million | -42.13 Million | -907 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 92 Thousand | -21 Thousand | 23.63 Million | 72 Thousand | - |
| Other Financing Activities | -17 Thousand | -72 Thousand | -9000.00 | -143 Thousand | -3000.00 | -74 Thousand |
| Accounts receivables | -53 Thousand | 1.15 Million | 249 Thousand | -898 Thousand | -1.44 Million | 15.73 Million |
| Accounts payables | -100 Thousand | 224 Thousand | -4.59 Million | -1.37 Million | 1.56 Million | 704 Thousand |
| Inventory | -1.14 Million | 571 Thousand | -163 Thousand | 54 Thousand | -93 Thousand | 310 Thousand |
| Other working capital | -1.16 Million | -1.13 Million | 123 Thousand | 6.6 Million | 4.01 Million | 779 Thousand |
| Cash at beginning of period | 32.64 Million | 44.54 Million | 59.75 Million | 40.44 Million | 27.41 Million | 26.34 Million |
| Cash at end of period | 19.15 Million | 32.64 Million | 44.54 Million | 44.54 Million | 59.75 Million | 27.41 Million |
| Capital Expenditure | -1.04 Million | -1.3 Million | -700 Thousand | -752 Thousand | -25 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -13.48 Million | -11.9 Million | -15.2 Million | 4.09 Million | 32.33 Million | 1.07 Million |
| Free Cash Flow | -13.1 Million | -7.12 Million | -17.13 Million | -38.56 Million | -10.12 Million | 1.99 Million |
CEM
1U1
ENVIP
3301
SHBI
USM